Microbiotix, Inc logo — company profile

Microbiotix, Inc

Founded 1998 18 employees Grant Total: $6.53M Biotechnology, Pharmaceutical

General Information

Company Name Microbiotix, Inc
Founded Year 1998
Founders / Decision Makers
Team member
Employees 18
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Microbiotix, Inc. To contact Microbiotix, Inc, visit microbiotix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Microbiotix, Inc compare?

A PDF of Microbiotix, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Microbiotix, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Microbiotix, Inc

Microbiotix, Inc. is a clinical stage biopharmaceutical company established in 1998 that focuses on developing proprietary small molecule drugs targeting serious infectious diseases, particularly multi-drug resistant pathogens. The company recently received a $2.07M grant investment on 21 November 2022 from the National Institute of Allergy and Infectious Diseases. Microbiotix operates within the Biotechnology and Pharmaceutical industries, positioning itself as a promising venture in the healthcare sector. With a clear focus on addressing critical medical challenges, Microbiotix's innovative approach and recent investment highlight a potential opportunity for growth and impact in the biopharmaceutical space.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.07M 1
National Institute of Allergy and Infectious Diseases
21 Nov 2022
Grant $2.86M 1
CARB-X
17 Mar 2020
Grant $1.60M 1
CARB-X
01 Apr 2017

Microbiotix, Inc Alternatives & Competitors

View All Alternatives
Microbiotix, Inc vs
Inspirna, Inc.
Inspirna, Inc. United States

Converting cancer to a manageable, chronic condition

Series D
12 employees
Biotechnology, Health Care
Microbiotix, Inc vs

Taking the Journey Towards Comprehensive Treatment of Serious Disease

Post-IPO Equity
63 employees
Biotechnology, Health Care
Microbiotix, Inc vs

ChemRoutes Corporation is a private drug discovery technology provider operating at the interface of...

Pre-Seed
6 employees
Biotechnology, Health Care

FAQ About Microbiotix, Inc

Microbiotix, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases, including multi-drug resistant pathogens.
Microbiotix, Inc was founded in 1998.
Microbiotix, Inc operates in Biotechnology and Pharmaceutical.
Microbiotix, Inc has approximately 18 employees.
Microbiotix, Inc has completed 3 funding rounds, raising a total of $6.53M. The latest funding stage is Grant.
Top alternatives and competitors to Microbiotix, Inc include Inspirna, Inc., Terns Pharmaceuticals, ChemRoutes Corporation, Structure Therapeutics, Santaris Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microbiotix, Inc and Inspirna, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Microbiotix, Inc, https://bouncewatch.com/company/microbiotix-inc, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes